Many must have used the products of the pharmaceutical company Sun Pharmaceuticals. Dilip Shanghvi, the founder of Sun Pharma Company, started this company with a loan of around two thousand rupees. At present, Dilip Sanghvi has become the owner of thousands of crores of rupees. There was a time when Dilip Sanghvi became the richest man in India after Mukesh Ambani.
Dilip Sanghvi started the company with 2000 loan
Who knew that this man born in the house of a drug dealer in Gujarat would one day become the head of the entire drug market. Dilip Sanghvi graduated from Calcutta and soon after he started thinking of doing business. He was named in Forbes Magazine’s list of billionaires.
Dilip Sanghvi borrowed Rs 2,000 from his father to start a business. Then Dilip Sanghvi started a company called Sun Pharma with five distributors.
Sun Pharma has a market cap of around Rs 2 lakh crore
At first, Dilip Sanghvi’s company only made medicines for certain mental illnesses. The portfolio of Dilip Sanghvir’s company then gradually expanded and today Sun Pharma, Dilip Sanghvir’s company, has included thousands of products, including several products like Volini and Revital. With this, the company has become the largest Indian pharmaceutical company listed on the stock exchange. Today, the market cap of Sun Pharma is around Rs 2 lakh crore.
Dilip Sanghvi has surpassed Mukesh Ambani
According to Forbes, Dilip Sanghvi currently owns about Rs 1,076 billion. In recent times, although Dilip Sanghvi may be out of the list of ten richest Indians, there was a time when Dilip Sanghvi became a rich Indian for some time, leaving behind a big businessman like Mukesh Ambani.
During the coronation period, Dilip Sanghvi’s wealth increased by 17 percent
The time of Covid-19 was bad for many, but many benefited from it. Dilip Sanghvi is one of those people who has benefited a lot during Corona’s tenure. By 2020, Dilip Sanghvi’s wealth has grown by about 17 per cent to Rs 12,500 crore. Shares of Dilip Sanghvi’s company Sun Pharma have risen more than 60 per cent in the last one year.